FABRICATION AND COMPARATIVE EVALUATION OF CURCUMIN AND PACLITAXEL- LOADED SOLID LIPID NANOPARTICLE; THE PATHWAY OF EFFECTIVE CANCER THERAPY
AbstractThe objective of the present study is to develop, evaluate and compare potent phytoconstituents of curcumin loaded solid lipid nanoparticles (CUR-SLN) and Paclitaxel loaded solid lipid nanoparticles (PTX-SLN) for the treatment of malignancy. Curcumin is an active phenolic compound of Curcuma longa as a promising phytoconstituent has been extensively studied over the past several years. The result of these studies has indicated that the curcumin (CUR) acts on multiple molecular targets to selectively kill tumor cells with low intrinsic toxicity. The well-known anticancer agent Paclitaxel (PTX) is used for its effectiveness in the treatment of a wide range of tumors cells. However, due to the hydrophobic nature of PTX limits its effective application as anticancer drug. This study utilizes the immense potential of nanotechnology, particularly SLNs, in improving safety & bioavailability of CUR and PTX. SLN was chosen due to their excellent lipoidal drug carrier properties, physiological compatibility, and economic standpoint. In this study physical mixture of CUR-SLN and PTX-SLN formulation and PTX-SLN formulation were examined on Ehrlich ascites carcinoma (EAC) cells for anticancer study. It was observed that the physical mixture of CUR-PTX and PTX-SLN was more effective than PTX-SLN.
Article Information
12
1110-1120
893
1079
English
IJPSR
P. Das, S. K. Roy, A. Guha and K. Kuotsu *
Department of Pharmaceutical Technology, Jadavpur University, Kolkata, West Bengal, India.
ketousetuoju@gmail.com
07 May 2019
16 August 2019
02 September 2019
10.13040/IJPSR.0975-8232.11(3).1110-20
01 March 2020